347 results on '"Ramassamy, Charles"'
Search Results
102. Optimization of Curcumin-Loaded PEG-PLGA Nanoparticles by GSH Functionalization: Investigation of the Internalization Pathway in Neuronal Cells
103. Challenges associated with curcumin therapy in Alzheimer disease
104. Standardized Extracts of Bacopa monniera Protect Against MPP+- and Paraquat-Induced Toxicity by Modulating Mitochondrial Activities, Proteasomal Functions, and Redox Pathways
105. Nanotechnology for Cerebral Delivery of Nutraceuticals for the Treatment of Neurodegenerative Diseases
106. Regulation of Redox-Sensitive Signaling Pathways in Rat Primary Astrocytes Following Acrolein Exposure
107. Nanoneuropharmacology: A challenging concept in pharmaceutical investigations for the next decade
108. Molecular Regulations Induced by Acrolein in Neuroblastoma SK-N-SH Cells: Relevance to Alzheimer's Disease
109. Role of By-Products of Lipid Oxidation in Alzheimer's Disease Brain: A Focus on Acrolein
110. Scientific Basis for the Use of Indian Ayurvedic Medicinal Plants in the Treatment of Neurodegenerative Disorders: 1. Ashwagandha
111. Modulation of Hydrogen Peroxide and Acrolein-Induced Oxidative Stress, Mitochondrial Dysfunctions and Redox Regulated Pathways by the Bacopa Monniera Extract: Potential Implication in Alzheimer's Disease
112. Potential Role of Acrolein in Neurodegeneration and in Alzheimers Disease
113. Biotransformed blueberry juice protects neurons from hydrogen peroxide-induced oxidative stress and mitogen-activated protein kinase pathway alterations
114. Proteomic analysis of brain protein expression levels in NF-κβ p50 −/− homozygous knockout mice
115. Faculty Opinions recommendation of Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model.
116. Challenges for Research on Polyphenols from Foods in Alzheimer’s Disease: Bioavailability, Metabolism, and Cellular and Molecular Mechanisms
117. Modifications of the Synaptosomal Dopamine Uptake and Release by Two Systems Generating Free Radicals: Ascorbic Acid/Fe2+ and l-Arginine/NADPH
118. Faculty Opinions recommendation of NF-kappaB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production.
119. Anti-hyperglycemic effect of fermented blueberry juice in STZ rats and KKAy mice
120. Innovative Anthocyanin/Anthocyanidin Formulation Protects SK-N-SH Cells Against the Amyloid- Peptide-Induced Toxicity: Relevance to Alzheimer’s Disease
121. Neuronal Uptake and Neuroprotective Properties of Curcumin-Loaded Nanoparticles on SK-N-SH Cell Line: Role of Poly(lactide-co-glycolide) Polymeric Matrix Composition
122. Phospholipase A2 activity is decreased selectively in the hippocampus of aged apolipoprotein E deficient mice
123. The ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by β-amyloid
124. Effect of Tacrine-3-caffeic Acid, A Novel Multifunctional Anti-Alzheimer's Dimer, Against Oxidative-Stress-Induced Cell Death in HT22 Hippocampal Neurons: Involvement of Nrf2/ HO-1 Pathway.
125. Apolipoprotein E and β-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent
126. Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage
127. Ginkgo Biloba Extract EGB 761 or Trolox C Prevent the Ascorbic Acid/FE2+Induced Decrease in Synaptosomal Membrane Fluidity
128. Prevention by Ginkgo biloba extract (EGb 761) and trolox C of the decrease in synaptosomal dopamine or serotonin uptake following incubation
129. Molecular regulations induced by acrolein in neuroblastoma SK-N-SH cells: relevance to Alzheimer's disease.
130. Fermented Canadian lowbush blueberry juice stimulates glucose uptake and AMP-activated protein kinase in insulin-sensitive cultured muscle cells and adipocytes.
131. Prevention by a Ginkgo biloba Extract (GBE 761) of the Dopaminergic Neurotoxicity of MPTP
132. Ginkgo Biloba Extract EGB 761 or Trolox C Prevent the Ascorbic Acid/FE2++ Induced Decrease in Synaptosomal Membrane Fluidity.
133. Modifications of the Synaptosomal Dopamine Uptake and Release by Two Systems Generating Free Radicals: Ascorbic Acid/Fe2+ and l-Arginine/NADPH.
134. Potential of Nanoparticulate Drug Delivery Systems by Intranasal Administration
135. Impact of apoE deficiency on oxidative insults and antioxidant levels in the brain
136. Isolation of Neuroprotective Anthocyanins from Black Chokeberry (Aronia melanocarpa) against Amyloid-β-Induced Cognitive Impairment.
137. Ginkgo Biloba Extract EGB 761 or Trolox C Prevent the Ascorbic Acid/FE2+ Induced Decrease in Synaptosomal Membrane Fluidity
138. Additional file 2 of Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer's disease
139. Additional file 2 of Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer's disease
140. Implication of Circulating Extracellular Vesicles-Bound Amyloid-β42 Oligomers in the Progression of Alzheimer's Disease.
141. DEVELOPMENT OF BIO-CONJUGATES FOR THE TREATMENT OF EXCITOTOXICITY DURING ALZHEIMER'S DISEASE.
142. Date seeds alleviate behavioural and neuronal complications of metabolic syndrome in rats.
143. Donepezil-loaded extracellular vesicles to mitigate both reactive oxygen species and inflammatory damage as a therapeutic approach for Alzheimer's disease.
144. Neuroprotective mechanisms of the standardized extract of Bacopa monniera in a paraquat/diquat-mediated acute toxicity.
145. Proteomic analysis of brain protein expression levels in NF-κβ p50 −/− homozygous knockout mice
146. Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer's disease.
147. Transport of PEGylated-PLA nanoparticles across a blood brain barrier model, entry into neuronal cells and in vivo brain bioavailability.
148. Periphery-confined particulate systems for the management of neurodegenerative diseases and toxicity: Avoiding the blood-brain-barrier challenge.
149. Profile of pathogenic proteins in total circulating extracellular vesicles in mild cognitive impairment and during the progression of Alzheimer's disease.
150. Blood-based redox-signature and their association to the cognitive scores in MCI and Alzheimer's disease patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.